Medicines Law & Policy
LightNews LightNews
banner
medslawpolicy.bsky.social
Medicines Law & Policy
@medslawpolicy.bsky.social
47 followers 3 following 22 posts
Closing the knowledge gap on access to medicines and international law. Find our resources here: https://medicineslawandpolicy.org
Posts Replies Media Videos
medslawpolicy.bsky.social
The Role of Activism in Shaping Law and Policies that Support Access to Medicines
This post is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans Frontières, and the Consumer Project...
medicineslawandpolicy.org
November 11, 2025 at 12:25 PM
medslawpolicy.bsky.social
Affordability, binding commitments to technology sharing, and transparency key in Pathogen Access and Benefit Sharing
We appreciate the opportunity to offer comments on the draft PABS annex text . Some preliminary comments: Affordability of Access: The current draft mentions "providing access to products" and "rapid...
medicineslawandpolicy.org
November 3, 2025 at 2:10 PM
medslawpolicy.bsky.social
Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year - expanding access and prolonging lives
Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope to parents unable to afford the...
medicineslawandpolicy.org
October 24, 2025 at 4:36 PM
medslawpolicy.bsky.social
Read ML&P's statement, delivered by @ellenthoen.bsky.social , at the opening session of the Intergovernmental Working Group on the Pandemic Agreement here: medicineslawandpolicy.org/2025/09/the-...
The IGWG process offers an opportunity to fulfil the equity objectives of the Pandemic Agreement | Medicines Law & Policy
medicineslawandpolicy.org
September 15, 2025 at 7:34 AM
medslawpolicy.bsky.social
The IGWG process offers an opportunity to fulfil the equity objectives of the Pandemic Agreement
Co-Chairs,  Thank you for the opportunity to make a brief intervention. Both the sharing of pathogens and the sharing of the benefits, including products and knowledge, resulting from this should...
medicineslawandpolicy.org
September 15, 2025 at 7:16 AM
medslawpolicy.bsky.social
WHO Members meet to finalise the Pathogen Access and Benefit Sharing Instrument
In May 2025, the WHO member states adopted the Pandemic Agreement, but they left the work to establish an instrument for Pathogen Access and Benefit Sharing (PABS) for a later...
medicineslawandpolicy.org
September 10, 2025 at 6:00 AM
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
Treatment for cystic fibrosis added to Essential Medicines List by the World Health Organization: A victory for campaigners, though prices still ‘toxic’: Check out our new block on the Essential Medicines List: medicineslawandpolicy.org/2025/09/trea...
September 5, 2025 at 4:50 PM
medslawpolicy.bsky.social
Treatment for cystic fibrosis treatments added to Essential Medicines by the World Health Organization: A victory for campaigners, though prices still ‘toxic’
The World Health Organization today announced it has added the cystic fibrosis combination treatment elexacaftor + tezacaftor + ivacaftor (brand name Trikafta) to its Model Lists of Essential Medicines (EML)...
medicineslawandpolicy.org
September 5, 2025 at 4:15 PM
medslawpolicy.bsky.social
US Authorisation of Non-Voluntary Use of Patents frequently used for health technologies
During the Covid-19 pandemic, the United States prioritised the rapid development of products needed to combat the health crisis.  Rapid product development was pursued through the use of a statute...
medicineslawandpolicy.org
September 4, 2025 at 11:29 AM
medslawpolicy.bsky.social
FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending HIV
On 18th June 2015, the US Food and Drug Administration (FDA) approved the use of long-acting antiretroviral medicine lenacapavir (LEN-LA), for the prevention of HIV, also known as pre-exposure prophylaxis...
medicineslawandpolicy.org
June 19, 2025 at 9:43 AM
medslawpolicy.bsky.social
Transfer of technology and know-how for the production of pandemic-related health products in the WHO Pandemic Agreement: the proverbial half glass 
A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot During the COVID-19 pandemic, the delayed...
medicineslawandpolicy.org
June 16, 2025 at 6:00 AM
medslawpolicy.bsky.social
The People vs. AbbVie
Today, 9 May 2025, is an important day in court for the Dutch Pharmaceutical Accountability Foundation (PAF). In February 2023, PAF started a court case against AbbVie, over AbbVie’s excessive...
medicineslawandpolicy.org
May 9, 2025 at 2:01 AM
medslawpolicy.bsky.social
The Pandemic Agreement is here
In December 2021, the member states of the World Health Organization decided “to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response”,...
medicineslawandpolicy.org
April 16, 2025 at 9:49 AM
medslawpolicy.bsky.social
Pharmaceutical patents and data exclusivity in an age of AI-driven drug discovery and development
This is an excerpt from a longer report on AI, medicines development and the patent system. Download the full report here (or by clicking on the image at left). Rapid...
medicineslawandpolicy.org
April 14, 2025 at 7:15 AM
medslawpolicy.bsky.social
Expanding local production is essential for pandemic preparedness. It requires, however, transfer of technology.
Madam co-chairs, delegates,  This very week, from 7 to 9 April the 3rd World Local Production Forum is taking place in Abu Dhabi. Actions towards expanding local production of medical...
medicineslawandpolicy.org
April 9, 2025 at 7:32 AM
medslawpolicy.bsky.social
Respect for intellectual property law includes respecting the flexibilities it contains to protect the public interest: ML&P’s opening statement to the INB
Thank you for the opportunity to speak. And for the latest draft of the pandemic agreementshared with us on 26 March. In particular, we were pleased to see in the...
medicineslawandpolicy.org
April 8, 2025 at 6:43 AM
medslawpolicy.bsky.social
Will Europe block the Pandemic Agreement because of one word?
This commentary originally appeared in the Brussels Times, and is available here. The Pandemic Agreement negotiations began in December of 2021. Sufficiently motivated by the devastation brought by the COVID-19...
medicineslawandpolicy.org
March 28, 2025 at 11:56 AM
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
"The footnote that could save millions of lives" - see @ellenthoen.bsky.social 's interview in The Conduit about the @who.int #PandemicAgreement and what is needed for real pandemic preparedness.
The footnote that could save millions of lives - The Conduit
www.theconduit.com
March 11, 2025 at 12:19 PM
medslawpolicy.bsky.social
“Mutually agreed terms and conditions,” says it all.
On 4 March, Politico reported that the Polish presidency of the Council of the European Union (EU) is expressing doubt that the Pandemic Agreement being negotiated at the World Health...
medicineslawandpolicy.org
March 6, 2025 at 12:13 PM
medslawpolicy.bsky.social
"This week, the medicines were not there": What is at stake in the pandemic agreement
Earlier this week I listened to a testimony from a community worker at a maternity ward where HIV-positive women gave birth. 17 babies were born. Under normal circumstances, simple antiretroviral...
medicineslawandpolicy.org
February 21, 2025 at 3:53 PM
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
Exciting news. Colombia issued its first compulsory license in 2024, to increase access to HIV medicines. Now patients are receiving the drugs they need. @medslawpolicy.bsky.social #enableaccess
shaillygupta.bsky.social Shailly Gupta @shaillygupta.bsky.social · Feb 19
A big win for people with HIV in Colombia who will now have access to this medicine for their treatment. And kudos to Colombian government for taking this much needed step of issuing complusory license amid pressure for pharma corporation. We need more of these actions in other countries now. #IDSky
Major Win: First Batch of Dolutegravir Arrives in Colombia Under a Compulsory License - Make Medicines Affordable
The first batch of generic version of dolutegravir (DTG), an antiretroviral drug used to treat HIV,  arrived in Colombia on Thursday as part of a compulsory license, marking a significant milestone fo...
makemedicinesaffordable.org
February 20, 2025 at 9:15 AM
medslawpolicy.bsky.social
A better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials
Antimicrobial resistance is the ‘silent’ pandemic: Globally, it costs 5 million lives a year, and is set to rise to more than 8 million lives lost a year by 2050....
medicineslawandpolicy.org
February 18, 2025 at 1:27 PM
medslawpolicy.bsky.social
The world needs a signal that multilateralism works: ML&P opening statement to the INB13, 17 February 2025: medicineslawandpolicy.org/2025/02/now-...
February 17, 2025 at 11:12 AM
medslawpolicy.bsky.social
New on ML&P: A guest blog by Suerie Moon of the Geneva Graduate Institute, synthesising expert opinion on Securing technology transfer in the Pandemic Agreement. Read it here: medicineslawandpolicy.org/2025/02/synt...
A man chops carrots into carrot sticks.
February 13, 2025 at 1:55 PM
Reposted by Medicines Law & Policy
kaitlinemara.bsky.social
@medslawpolicy.bsky.social ML&P's newest article on the impact of the humanitarian pause on @altusaid.bsky.social and PEPFAR, and how it threatens to undo decades of progress to fight the HIV pandemic #enableaccess medicineslawandpolicy.org/2025/02/trum...
February 5, 2025 at 10:05 AM